Magnesium and pH imaging of the human brain at 3.0 Tesla

Magnetic Resonance in Medicine

Volumn 41, Issue 2, 1999, Pages 400-406

  Barker, Peter B ^a,b,c   Butterworth, Edward J ^a,b   Boska, Michael D ^a,b   Nelson, Jay ^a   Welch, K M A ^a  

^a HENRY FORD HOSPITAL   (United States)

^b OAKLAND UNIVERSITY   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

31 phosphorus; Magnesium; pH; Spatial resolution; Spectroscopic imaging

Indexed keywords

ADENOSINETRIPHOSPHATE; BRAIN; CHROMIUM COMPOUNDS; IMAGE RESOLUTION; MAGNESIUM; MAGNETIC RESONANCE; METABOLITES; PH; PHOSPHATES; PHOSPHORUS; SIGNAL TO NOISE RATIO;

31-PHOSPHORUS; INORGANIC PHOSPHATES; MAGNESIUM CONCENTRATIONS; METABOLITE CONCENTRATIONS; PHOSPHODIESTERS; REGIONAL VARIATION; SPATIAL RESOLUTION; SPECTROSCOPIC IMAGING;

MAGNESIUM METALLOGRAPHY;

ADENOSINE TRIPHOSPHATE; CREATINE PHOSPHATE; MAGNESIUM; ORGANOPHOSPHATE; PHOSPHATE; PHOSPHORUS 31;

ADULT; ARTICLE; BRAIN RADIOGRAPHY; CALCULATION; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PH; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE;

EID: 0032966735     PISSN: 07403194     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1522-2594(199902)41:2<400::AID-MRM26>3.0.CO;2-E     Document Type: Article

References (39)

1. 31P MRS spectra in determining intracellular free magnesium and potassium ion concentrations. Magn Reson Med 1995;33:467-474.
2. Cohn M, Hughes T. Nuclear magnetic resonance spectra of adenosine di- and triphosphate. II. Effect of comploxing with divalent metal ions. J Biol Chem 1962;22:176-181.
3. 31P NMR. J Biol Chem 1978;253:6172-6176.
4. 31P NMR in vivo. NMR Biomed 1992;5:53-58.
5. 31P magnetic resonance. J Biol Chem 1973;248:7276-7278.
6. 31P nuclear magnetic resonance spectroscopy. Neurology 1985;35:781-788.
7. 31P NMR spectroscopy. Magn Reson Med 1992;24:163-169.
8. 31P NMR chemical shifts of ATP. Anal Biochem 1993;214:458-467.
9. Garfinkel L, Altschuld RA, Garfinkel D. Magnesium in cardiac energy metabolism. J Mol Cell Cardiol 1986;18:1003-1013.
10. 31P chemical-shift imaging measurements at 1.5 T. Proc Natl Acad Sci USA 1991;88:6810-6814.
11. Cadoux-Hudson TA, Blackledge MJ, Rajagopalan B, Taylor DJ, Radda GK. Human primary brain tumour metabolism in vivo: a phosphorus magnetic resonance spectroscopy study. Br J Cancer 1989;80:430-436.
12. Arnold DL, Emrich JF, Shoubridge EA, Villemure J-G, Feindel W. Characterization of astrocytomas, meningiomas, and pituitary adenomas bu phosphorus magnetic resonance spectroscopy. J Neurosurg 1991;74:447-453.
13. Helpern JA, Vande Linde AMQ, Welch KMA, Levine SR, Schultz LR, Ordidge RJ, Halvorson HR, Hugg JW. Acute elevation and recovery of intracellular [Mg2+] following human focal cerebral ischemia. J Neurology 1993;43:1577-1581.
14. Levine SR, Helper JA, Welch KMA, Vande Linde AMQ, Sawaya KL, Brown EE, Ramadan NM, Deveshwar RK, Ordidge RJ. Human focal cerebral ischemia: evaluation of brain pH an energy metabolism with P-31 NMR spectroscopy. Radiology 1992;185:537-544.
15. Ramadan NM, Halvorson H, Vande-Linde A, Levine SR, Helpern JA, Welch KMA. Low brain magnesium in migraine. Headache 1989;29:590-593.
16. Hubesch B, Sappey MD, Roth K, Meyerhoff DJ, Matson GB, Weiner MW. P-31 MR spectroscopy of normal human brain and brain tumors. Radiology 1990;174:401-409.
17. Bottomley PA, Charles HC, Roemer PB, Flamig D, Engeseth H, Edelstein WA, Mueller OM. Human in vivo phosphate metabolite imaging with 31P NMR. Magn Reson Med 1988;7:319-36.
18. Vigneron DB, Nelson SJ, Murphy BJ, Kelley DA, Kessler HB, Brown TR, Taylor JS. Chemical shift imaging of human brain: axial, sagittal, and coronal P-31 metabolite images. Radiology 1990;177:643-649.
19. Mason GF, Chu W-J, Vaughan JT, Ponder SL, Twieg DB, Adams D, Hetherington HP. Evaluation of 31P metabolic differences in human cerebral gray and white matter. Magn Reson Med 1998;39:346-353.
20. Hardy CJ, Bottomley PA, Roemer PB, Redington RW. Rapid 31P spectroscopy on a 4-T whole-body system. Magn Reson Med 1988;8:104-109.
21. Barker PB, Sibisi S. Proceedings of the 9th annual meeting of the Society of Magnetic Resonance in Medicine. New York, 1990, p 1089.
22. Press WH, Flannery BP, Tenkolsky SA, Votterling WT. Numerical recipes in C: the art of scientific computing. Cambridge: Cambridge University Press; 1990.
23. Golding EM, Dobson GP, Golding RM. A critical assessment of noise-induced errors in 31P MRS: application to the measurement of free intracellular magnesium in vivo. Magn Reson Med 1996;35:174-185.
24. Bottomley PA, Hardy CJ. Rapid, reliable in vivo assays of human phosphate metabolites by nuclear magnetic resonance. Clin Chem 1989;35:392-395.
25. 2+ concentrations. J Biol Chem 1973;248:4811-4819.
26. 2+ and other ions in solution: calculation of the true concentrations of species present in mixtures of associating ions. Binohem J 1976;159:1-5.
27. 2+ concentration in adenosino 5′-triphosphate containing solutions in vitro and in vivo. Biochemistry 1984;23:3547-3552.
28. Gupta RK, Benovic JL. Magnetic resonance studies of the interaction of divalent metal cations with 2,3-bisphosphoglycerate. Biochem Biophys Comm 1978;84:130-137.
29. Wu ST, Pieper GM, Salhany JM, Ellis RS. Measurement of free magnesium in perfused and ischemic arrested heart muscle. A quantitative phosphorous-31 nuclear magnetic resonance and multiequilibria analysis. Biochemistry 1981;20:7399-7403.
30. 31P-NMR spectroscopy. Biochim Biophys Act 1986;885:1-11.
31. Petroff OAC, Prichard JW, Behar KL, Alger JR, Shulman RG. In vivo phosphorus nuclear magnetic resonance spectroscopy in status epilepticus. Annal Neurol 1984;16:169-177.
32. Bates TE, Williams SR, Gadian DG. Phosphodiesters in the liver: the effect of field strength on the 31P signal. Magn Reson Med 1989;12:145-150.
33. Cao Y, Meyers K, Barker PB, Ewing JR, Boska MD. Proceedings of the third annual meeting of the Society of Magnetic Resonance, Nice, France, 1995, p 697.
34. Le Fur Y, Ziegler A, Bourgeois D, Decorps M, Remy C. Phased spectroscopic images: application to the characterization of the 1H 1.3 ppm resonance in the intracerebral tumors in the rat. Magn Reson Med 1993;29:431-435.
35. Maudsley AA, Matson GB, Hugg JW, Weiner MW. Reduced phase encoding in spectroscopic imaging. Magn Reson Med 1994;31:645-851.
36. Shaka AJ, Keeler J, Freeman R. Evaluation of a new broadband decoupling sequence: WALTZ-16. J Magn Reson 1983;53:313-340.
37. Luyten PR, Bruntink G, Sloff FM, Vermeulen JW, van der Heijden JI, den Hollander JA, Heerschap A. Broadband proton decoupling in human 31P NMR spectroscopy. NMR Biomed 1989;1:177-183.
38. 31P spectroscopy of the human head. J Magn Reson B 1994;103:103-114.
39. Twieg DB, Hetherington HP, Ponder SL, den Hollander JA, Pohost GM. Spatial resolution in 31P metabolite imaging of the human brain at 4.1 T. J Magn Reson B 1994;104:153-158.